Literature DB >> 21388406

Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Raul M Luque1, Manuel D Gahete, Jose Cordoba-Chacon, Gwen V Childs, Rhonda D Kineman.   

Abstract

Circulating growth hormone (GH) levels rise in response to nutrient deprivation and fall in states of nutrient excess. Because GH regulates carbohydrate, lipid, and protein metabolism, defining the mechanisms by which changes in metabolism alter GH secretion will aid in our understanding of the cause, progression, and treatment of metabolic diseases. This review will summarize what is currently known regarding the impact of systemic metabolic signals on GH-axis function. In addition, ongoing studies using the Cre/loxP system to generate mouse models with selective somatotrope resistance to metabolic signals will be discussed, where these models will serve to enhance our understanding of the specific role the somatotrope plays in sensing the metabolic environment and adjusting GH output in metabolic extremes.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388406      PMCID: PMC3444739          DOI: 10.1111/j.1749-6632.2010.05913.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  103 in total

1.  Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests.

Authors:  Xiao-Dan Qu; Irene T Gaw Gonzalo; Mohammed Y Al Sayed; Pejman Cohan; Peter D Christenson; Ronald S Swerdloff; Daniel F Kelly; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

2.  Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.

Authors:  G Aleppo; S F Moskal; P A De Grandis; R D Kineman; L A Frohman
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

3.  Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.

Authors:  R D Kineman; J Kamegai; L A Frohman
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

4.  Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice.

Authors:  Tong-Jin Zhao; Guosheng Liang; Robert Lin Li; Xuefen Xie; Mark W Sleeman; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

5.  Role of Glucocorticoids in Fasting-induced Changes in Hypothalamic and Pituitary Components of the Growth Hormone (GH)-axis.

Authors:  Eunhee Kim; Sanghee Seo; Hyunju Chung; Seungjoon Park
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

6.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

7.  Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

Authors:  Nina Balthasar; Roberto Coppari; Julie McMinn; Shun M Liu; Charlotte E Lee; Vinsee Tang; Christopher D Kenny; Robert A McGovern; Streamson C Chua; Joel K Elmquist; Bradford B Lowell
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

8.  Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.

Authors:  Raul M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2006-03-02       Impact factor: 4.736

9.  Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome.

Authors:  Rocco Barazzoni; Michela Zanetti; Clara Ferreira; Pierandrea Vinci; Alessia Pirulli; Mariapia Mucci; Franca Dore; Maurizio Fonda; Beniamino Ciocchi; Luigi Cattin; Gianfranco Guarnieri
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

10.  Glucose and free fatty acid modulation of growth hormone and luteinizing hormone secretion by cultured porcine pituitary cells.

Authors:  C R Barb; R R Kraeling; G B Rampacek
Journal:  J Anim Sci       Date:  1995-05       Impact factor: 3.159

View more
  13 in total

1.  Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy.

Authors:  Pamela U Freda; Carlos Reyes-Vidal; Zhezhen Jin; Mya Pugh; Sunil K Panigrahi; Jeffrey N Bruce; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

2.  Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates.

Authors:  Alejandro Ibáñez-Costa; José Córdoba-Chacón; Manuel D Gahete; Rhonda D Kineman; Justo P Castaño; Raúl M Luque
Journal:  Endocrinology       Date:  2014-12-29       Impact factor: 4.736

3.  Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men.

Authors:  Ali Iranmanesh; Donna Lawson; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2012-04-03       Impact factor: 5.958

4.  Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin.

Authors:  José Córdoba-Chacón; Manuel D Gahete; Ana I Pozo-Salas; Antonio J Martínez-Fuentes; Luis de Lecea; Francisco Gracia-Navarro; Rhonda D Kineman; Justo P Castaño; Raul M Luque
Journal:  Endocrinology       Date:  2011-10-04       Impact factor: 4.736

5.  Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Chike V Anadumaka; Qing Lin; Jens C Brüning; C Ronald Kahn; Raúl M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2011-10-11       Impact factor: 4.736

6.  A Sex-Dependent, Tropic Role for Leptin in the Somatotrope as a Regulator of POU1F1 and POU1F1-Dependent Hormones.

Authors:  Angela K Odle; Melody L Allensworth-James; Noor Akhter; Mohsin Syed; Anessa C Haney; Melanie MacNicol; Angus M MacNicol; Gwen V Childs
Journal:  Endocrinology       Date:  2016-08-29       Impact factor: 4.736

7.  Obesity alters gene expression for GH/IGF-I axis in mouse mammary fat pads: differential role of cortistatin and somatostatin.

Authors:  Alicia Villa-Osaba; Manuel D Gahete; José Córdoba-Chacón; Luis de Lecea; Ana I Pozo-Salas; Francisco Javier Delgado-Lista; Marina Álvarez-Benito; José López-Miranda; Raúl M Luque; Justo P Castaño
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

8.  Obesity- and gender-dependent role of endogenous somatostatin and cortistatin in the regulation of endocrine and metabolic homeostasis in mice.

Authors:  Raúl M Luque; José Cordoba-Chacon; Ana I Pozo-Salas; Begoña Porteiro; Luis de Lecea; Rubén Nogueiras; Manuel D Gahete; Justo P Castaño
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

9.  Adipokines (Leptin, Adiponectin, Resistin) Differentially Regulate All Hormonal Cell Types in Primary Anterior Pituitary Cell Cultures from Two Primate Species.

Authors:  André Sarmento-Cabral; Juan R Peinado; Lisa C Halliday; María M Malagon; Justo P Castaño; Rhonda D Kineman; Raúl M Luque
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

10.  Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.

Authors:  Raúl M Luque; Alicia Villa-Osaba; Fernando L-López; Ana I Pozo-Salas; Rafael Sánchez-Sánchez; Rosa Ortega-Salas; Luis de Lecea; Marina Álvarez-Benito; José López-Miranda; Manuel D Gahete; Justo P Castaño
Journal:  Breast Cancer Res       Date:  2016-03-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.